← Back to headlines
Judge Rejects Bayer Bid to Block J&J Prostate Cancer Drug Claims
A U.S. judge has rejected Bayer's attempt to block claims related to Johnson & Johnson's prostate cancer drug. This ruling allows the legal proceedings concerning the drug to continue.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
